SBTX - Silverback Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Silverback Therapeutics 's activity chart (see below) currently has 14 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.44% with an average time for these price targets to be met of 28 days.

Most recent stock forecast was given by from STIFEL on 13-May-2022. First documented stock forecast 29-Dec-2020.

Best performing analysts who are covering SBTX - Silverback Therapeutics :

Stephen Willey Daina Graybosch Paul Choi Soumit Roy Edward White

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-May-2022

$5

$-0.87 (-14.82%)

$6

Buy Since 29-Dec-2020

$1.8

$-4.07 (-69.34%)

Buy Since 29-Dec-2020

$48

$42.13 (717.72%)

$43

Show more analysts

Please expand the browser size to see the chart

What is SBTX (Silverback Therapeutics ) average time for price targets to be met?

On average it took 28 days on average for the stock forecasts to be realized with a an average price target met ratio 54.44

Which analyst has the current highest performing score on SBTX (Silverback Therapeutics ) with a proven track record?

STEPHEN WILLEY

Which analyst has the most public recommendations on SBTX (Silverback Therapeutics )?

Stephen Willey works at STIFEL and has 39 price targets and 25 ratings on SBTX

Which analyst is the currently most bullish on SBTX (Silverback Therapeutics )?

Paul Choi with highest potential upside - $42.13

Which analyst is the currently most reserved on SBTX (Silverback Therapeutics )?

Daina Graybosch with lowest potential downside - -$4.07

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?